Alternative to Clinical Site Visits During COVID-19 & Beyond
Posted | November 15, 2021A patient with a rare immune deficiency was able to continue clinical trial participation during the coronavirus pandemic.
Stay informed on the latest insights, innovations, and best practices in decentralized clinical trials (DCTs). Explore how remote models, digital health tools, and patient-first approaches are transforming trial accessibility, participation, and data quality worldwide.